Scientific Industries Inc (SCND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60 | N/A | -280 | -299 | -161 |
| Depreciation Amortization | 105 | N/A | 327 | 220 | 110 |
| Income taxes - deferred | -18 | N/A | -37 | -15 | -4 |
| Accounts receivable | 344 | N/A | -73 | 26 | -39 |
| Accounts payable and accrued liabilities | -27 | N/A | -49 | 49 | -32 |
| Other Working Capital | -75 | N/A | -224 | -322 | -211 |
| Other Operating Activity | -315 | 0 | 141 | -66 | 77 |
| Operating Cash Flow | $-44 | $N/A | $-195 | $-408 | $-260 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | N/A | -57 | -53 | -20 |
| Purchase Of Investment | N/A | N/A | 123 | 71 | 75 |
| Purchase Sale Intangibles | N/A | N/A | -4 | -3 | -1 |
| Other Investing Activity | 0 | 0 | -4 | -3 | -1 |
| Investing Cash Flow | $-7 | $N/A | $62 | $15 | $54 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 200 | N/A | 250 | 250 | 200 |
| Debt Repayment | N/A | N/A | -177 | -27 | -20 |
| Common Stock Issued | N/A | N/A | 19 | 19 | 19 |
| Other Financing Activity | -101 | 0 | -99 | -99 | -99 |
| Financing Cash Flow | $99 | $N/A | $-7 | $143 | $100 |
| Beginning Cash Position | 482 | N/A | 494 | 494 | 494 |
| End Cash Position | 530 | N/A | 354 | 244 | 388 |
| Net Cash Flow | $48 | $N/A | $-139 | $-250 | $-106 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44 | N/A | -195 | -408 | -260 |
| Capital Expenditure | -7 | N/A | -57 | -53 | -20 |
| Free Cash Flow | -51 | 0 | -251 | -461 | -279 |